Tokyo, Japan

Ken Yamakawa


 

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ken Yamakawa: Pioneering Innovations in Platinum Complexes

Introduction

Ken Yamakawa, a notable inventor based in Tokyo, Japan, has made significant contributions to the field of medicinal chemistry through his innovative work on platinum complexes. With a total of three patents, Yamakawa is recognized for his endeavors in developing novel compounds with essential medical applications aimed at treating cancer.

Latest Patents

Yamakawa's latest patents include groundbreaking advancements in platinum complexes that show promise in clinical settings. His first patent, focused on a **Platinum (IV) complex**, addresses the pressing demand for novel compounds with sufficient water solubility, stability, and antitumor activity. This complex is pivotal for its potential clinical applications, represented by a specific general formula designed to encompass a variety of halogen atoms.

The second remarkable patent is for a **Polymer conjugate of sulfoxide derivative-coordinated platinum(II) complex**. This innovative drug delivery system (DDS) demonstrates superior antitumor effects while minimizing side effects. The polymer conjugate uses a block copolymer containing both polyethylene glycol and either polyaspartic or polyglutamic acid moieties, along with a sulfoxide derivative that facilitates coordination with the platinum(II) complex.

Career Highlights

Ken Yamakawa is employed at Nippon Kayaku Kabushiki Kaisha, a company recognized for its dedication to pharmaceutical advancements. His tenure at this esteemed organization highlights his commitment to advancing medicinal chemistry and showcases the innovative spirit he brings to his work.

Collaborations

Throughout his career, Yamakawa has collaborated with esteemed colleagues, including Masaharu Nakamura and Tsuyoshi Fukuda. Their combined expertise contributes to the development and refinement of innovative therapeutic agents and enhances the overall research outcomes produced at their company.

Conclusion

Ken Yamakawa stands out as a remarkable inventor in the realm of platinum complexes, developing formulations that promise to revolutionize cancer treatment. His contributions through patents not only reflect his dedication to medical science but also signify the potential impact of his work on future therapeutic approaches.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…